Sponsor pipeline

PedAL BCU, LLC clinical trial pipeline

Get alerts when PedAL BCU, LLC's trials change

3 active trials 3 recruiting 1 Phase 3 5 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05183035 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia Recruiting 2026-08-24
Phase 1/2
NCT04726241 The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and… Acute Lymphoblastic Leukemia Recruiting 2026-08-25
Phase 1
NCT06376162 Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute… Relapsed/Refractory KMT2A-r Acute Leukemia Recruiting 2026-10-09

Disease areas by active trials

Leukemia (3) · Acute Myeloid Leukemia (AML) (2) · Acute Lymphoblastic Leukemia (ALL) (1) · MDS/MPN Overlap (1) · Myelodysplastic Syndromes (MDS) (1)

Get alerts when PedAL BCU, LLC's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free